» Articles » PMID: 38371421

Evaluate the Effects of Low-intensity Pulsed Ultrasound on Dental Implant Osseointegration Under Type II Diabetes

Overview
Date 2024 Feb 19
PMID 38371421
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study is to assess the impact of low-intensity pulsed ultrasound (LIPUS) therapy on the peri-implant osteogenesis in a Type II diabetes mellitus (T2DM) rat model. A total of twenty male Sprague-Dawley (SD) rats were randomly allocated into four groups: Control group, T2DM group, Control-LIPUS group, and T2DM-LIPUS group. Implants were placed at the rats' bilateral maxillary first molar sites. The LIPUS treatment was carried out on the rats in Control-LIPUS group and T2DM-LIPUS group, immediately after the placement of the implants, over three consecutive weeks. Three weeks after implantation, the rats' maxillae were extracted for micro-CT, removal torque value (RTV), and histologic analysis. Micro-CT analysis showed that T2DM rats experienced more bone loss around implant cervical margins compared with the non-T2DM rats, while the LIPUS treated T2DM rats showed similar bone heights to the non-T2DM rats. Bone-implant contact ratio (BIC) were lower in T2DM rats but significantly improved in the LIPUS treated T2DM rats. Bone formation parameters including bone volume fraction (BV/TV), trabecular thickness (Tb.Th), bone mineral density (BMD) and RTV were all positively influenced by LIPUS treatment. Histological staining further confirmed LIPUS's positive effects on peri-implant new bone formation in T2DM rats. As an effective and safe treatment in promoting osteogenesis, LIPUS has a great potential for T2DM patients to attain improved peri-implant osteogenesis. To confirm its clinical efficacy and to explore the underlying mechanism, further prospective cohort studies or randomized controlled trials are needed in the future.

References
1.
Harrison A, Alt V . Low-intensity pulsed ultrasound (LIPUS) for stimulation of bone healing - A narrative review. Injury. 2021; 52 Suppl 2:S91-S96. DOI: 10.1016/j.injury.2021.05.002. View

2.
Wang L, Gao Z, Liu C, Li J . Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus. BMC Oral Health. 2021; 21(1):583. PMC: 8603511. DOI: 10.1186/s12903-021-01939-9. View

3.
Zhang B, Chen H, Ouyang J, Xie Y, Chen L, Tan Q . SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect. Autophagy. 2019; 16(7):1262-1278. PMC: 7469634. DOI: 10.1080/15548627.2019.1664705. View

4.
Liu J, Wu Z, He H, Cai K, Zhang H, Xu L . Gallium and silicon synergistically promote osseointegration of dental implant in patients with osteoporosis. Med Hypotheses. 2017; 103:35-38. DOI: 10.1016/j.mehy.2017.02.018. View

5.
Zhang B, Liu N, Shi H, Wu H, Gao Y, He H . High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3β. J Bone Miner Metab. 2015; 34(2):140-50. DOI: 10.1007/s00774-015-0662-6. View